(Q62110124)

English

Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

clinical trial

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

title

A Randomized, Double-Blind, Placebo-Controlled, Phase IIB Study of the Safety and Efficacy of OVAREX MabB43.13 in Ovarian Cancer Patients With an Elevated Serum CA 125 But Without Other Evidence of Disease (English)

0 references

country

Canada

0 references

United States of America

0 references

start time

November 1998

0 references

number of participants

102

0 references

research intervention

Oregovomab

0 references

clinical trial phase

phase II clinical trial

0 references

research site

Gynecologic Oncology Associates

0 references

University of Oklahoma

0 references

Washington University in St. Louis

0 references

Fox Chase Cancer Center

0 references

research subject recruitment status

unknown

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00004064

0 references

(Q62110124)

Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)